Radiation-induced Parotid Gland Atrophy in Patients with Head and Neck Cancer After Carbon-ion Radiotherapy.

BACKGROUND/AIM This study aimed to clarify the relationship between dosimetric factors and parotid gland (PG) atrophy after carbon ion radiotherapy (C-ion RT). PATIENTS AND METHODS Fifty-four patients with head and neck tumours were enrolled and 93 irradiated PGs were analyzed. Thirty and 24 patients were treated with total doses [relative biological effectiveness (RBE)] of 57.6 Gy and 64.0 Gy, respectively, in 16 fractions. PG volumes were measured using computed tomographic images obtained before C-ion RT and every 3-6 months thereafter. RESULTS The median follow-up period was 46.4 months (range=24.0-123.0 months). Univariate analysis showed that PG volumes receiving more than 5, 10, 15, and 20 Gy RBE (V5, V10, V15 and V20, respectively), mean dose, and maximum dose were significantly associated with PG atrophy. Multivariate analysis indicated that only V5 was significantly associated with atrophy. CONCLUSION Increasing V5 was a significant risk factor for PG atrophy after C-ion RT.

[1]  T. Shirai,et al.  Reformulation of a clinical-dose system for carbon-ion radiotherapy treatment planning at the National Institute of Radiological Sciences, Japan , 2015, Physics in medicine and biology.

[2]  Shinji Sato,et al.  Evaluation of hybrid depth scanning for carbon-ion radiotherapy. , 2012, Medical physics.

[3]  Tadashi Kamada,et al.  Results of carbon ion radiotherapy for head and neck cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  G. Hildebrandt,et al.  Parotid gland-recovery after radiotherapy in the head and neck region - 36 months follow-up of a prospective clinical study , 2011, Radiation oncology.

[5]  Emma Hall,et al.  Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial , 2011, The Lancet. Oncology.

[6]  Joseph O Deasy,et al.  Radiotherapy dose-volume effects on salivary gland function. , 2010, International journal of radiation oncology, biology, physics.

[7]  W. Mendenhall,et al.  Radiation‐induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: A longitudinal study , 2009, The Laryngoscope.

[8]  R. T. Ten Haken,et al.  The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy. , 2007, International journal of radiation oncology, biology, physics.

[9]  P. Choudhury,et al.  Can dose reduction to one parotid gland prevent xerostomia?--A feasibility study for locally advanced head and neck cancer patients treated with intensity-modulated radiotherapy. , 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

[10]  Joseph O Deasy,et al.  Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. , 2005, International journal of radiation oncology, biology, physics.

[11]  E. B. Butler,et al.  Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique. , 2003, International journal of radiation oncology, biology, physics.

[12]  S Minohara,et al.  Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. , 1999, International journal of radiation oncology, biology, physics.

[13]  M. Martel,et al.  Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results. , 1996, International journal of radiation oncology, biology, physics.

[14]  T. Pajak,et al.  Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.

[15]  J. Cooper,et al.  Late effects of radiation therapy in the head and neck region. , 1995, International journal of radiation oncology, biology, physics.

[16]  T Kanai,et al.  Irradiation of mixed beam and design of spread-out Bragg peak for heavy-ion radiotherapy. , 1997, Radiation research.

[17]  K. Ang,et al.  Target cell and mode of radiation injury in rhesus salivary glands. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.